摘要
目的研究P-选凝素糖蛋白配体1(P-selectin glycoprotein ligand 1,PSGL-1)在ApcMin/+小鼠肠道肿瘤中的作用。方法PSGL-1基因缺失的基因工程小鼠和肠道肿瘤模型ApcMin/+小鼠杂交后,统计ApcMin/+小鼠与(ApcMin/+;PSGL-1-/-)杂交小鼠小肠及大肠肿瘤的数目和总负荷,观测其肠道肿瘤的发生变化。结果相比ApcMin/+小鼠,(ApcMin/+;PSGL-1-/-)杂交小鼠在18周龄时肠道肿瘤数目与总负荷有明显增加。结论 PSGL-1的缺失促进了ApcMin/+小鼠肠道肿瘤的发生,PSGL-1在人类肠道肿瘤中可能发挥着抑制肿瘤形成的作用。
Purpose To investigate the role of P-selectin glycoprotein ligand 1 ( PSGL-1 ) in ApcMin/+ mice intestinal tumors. Methods ApeMiKe+ was crossed with PSGL-l-deficient mice and the tumor susceptibility in intestine was compared. The small intestine and co- lon tumor number and the total tumor volume of ApcMin/+ mice and ApcMin/+ , PSGL-1 -/- mice were analyzed and the changes in intestinal tumor were observed. Results PSGL-1 deficiency in ApeMin/+ mice resulted in significant increase of tumor numbers and tumor vol- umes in the small intestine and total intestine at 18 weeks. Conclusion These findings have provided the genetic evidence for a tumor suppression role of PSGL-1 in the intestine of mice. Importantly, these studies also suggest that PSGL-1 may be a tumor suppressor for human intestinal tumors.
出处
《临床与实验病理学杂志》
CAS
CSCD
北大核心
2012年第5期495-498,共4页
Chinese Journal of Clinical and Experimental Pathology
基金
国家自然科学基金(30900764
21005022)
国家科技部"973"项目(2010CB529702)